Medullary thyroid carcinoma: surgical treatment advances

Gianlorenzo Dionigi1, Maria Laura Tanda, Eliana Piantanida

  • 1Department of Surgical Sciences, University of Insubria, Varese, Italy. gianlorenzo.dionigi@uninsubria.it

Abstract

Insights

New molecular diagnostics and endoscopic techniques are advancing medullary thyroid cancer treatment. Genetic screening for RET proto-oncogene mutations enables effective prophylactic surgery and minimally invasive endoscopic thyroidectomy.

Area of Science:

  • Oncology
  • Genetics
  • Surgical Innovation

Background:

  • Medullary thyroid cancer (MTC) treatment has seen advancements with new technologies.
  • Molecular diagnosis and endoscopic procedures are key innovations in thyroid surgery.

Purpose of the Study:

  • To review medical literature on the impact of new technologies in MTC treatment.
  • To highlight contributions of recent research to established MTC management recommendations.

Main Methods:

  • Literature search of relevant medical publications up to October 2007.
  • Analysis of studies focusing on molecular diagnosis and endoscopic procedures in MTC.

Main Results:

  • RET proto-oncogene mutations are causative in familial MTC.
  • Genetic screening for RET mutations improves MTC work-up and identifies candidates for prophylactic surgery.
  • Cervical endoscopic procedures, including video-assisted thyroidectomy with central compartment dissection, are feasible, safe, and effective for RET carriers.

Conclusions:

  • Recent literature offers significant insights into novel MTC treatment technologies.
  • New findings support and refine existing recommendations for MTC management.
  • Molecular diagnostics and minimally invasive surgery represent key advancements in MTC care.

Related Concept Videos